News archive for Brain tumour immunology and therapy group
BORTEM-17 interim analysis results and small molecule inhibitor targeting CSPG4/NG2 in glioblastoma at American Association for Cancer Research (AACR 2024) April 5-10, 2024
BORTEM-17 interim analysis results and small molecule inhibitor targeting CSPG4/NG2 in glioblastoma at American Association for Cancer Research (AACR 2024) April 5-10, 2024
It was a great privilege to participate at ‘AACR Annual Meeting 2024’, a large and important conference for cancer research, the place where scientists, clinicians, survivors, and patients, gather to share and discuss the latest breakthroughs.
- August 2024 (1)
- June 2024 (3)
- September 2023 (2)
- May 2023 (1)
- September 2021 (1)
- May 2021 (1)
- March 2021 (1)
- February 2021 (1)
- October 2020 (1)
- September 2019 (1)
- August 2019 (1)
- November 2018 (1)
- October 2018 (1)
- May 2018 (1)
- April 2018 (1)
- November 2017 (1)
- June 2014 (1)